Cancer Research Coordinating Committee (CRCC) Funded Publications

Parent: University of California Research Initiatives

eScholarship stats: History by Item for September through December, 2024

ItemTitleTotal requests2024-122024-112024-102024-09
8ck6g0xpA DNA aptamer for binding and inhibition of DNA methyltransferase 1.2627143
0ww2h0j5Erythrocyte-derived nano-probes functionalized with antibodies for targeted near infrared fluorescence imaging of cancer cells257558
9wq0h1n3Adenosine A2a receptors form distinct oligomers in protein detergent complexes247791
17z5v0x6Regulation of the T-box transcription factor Tbx3 by the tumour suppressor microRNA-206 in breast cancer227681
9qw9t9zcStructure and function of G protein-coupled receptor oligomers: implications for drug discovery216186
3012r2z7Copy number networks to guide combinatorial therapy of cancer and proliferative disorders203395
3c03q2r2Rapid Enrichment and Detection of Extracellular Vesicles Enabled by CuS-Enclosed Microgels.205762
46n9603rScalable Total Synthesis, IP3R Inhibitory Activity ofDesmethylxestospongin B, and Effect on Mitochondrial Function andCancer Cell Survival197372
6476b5jsAutomatic Small RNA Extraction and Processing by a Multichannel/Multiwell Chip185562
65m374m7Oil-in-Water-in-Oil Multinanoemulsions for Templating Complex Nanoparticles184356
0d34348tMetabolite Responsive Nanoparticle-Protein Complex145261
17k970vvSyrbactin Structural Analog TIR-199 Blocks Proteasome Activity And Induces Tumor Cell Death.143155
4wn320f9Asymmetric dimerization of adenosine deaminase acting on RNA facilitates substrate recognition.134144
7f71c92qInvestigations into Wnt modulation of p27(KIP1) turnover and the E3 ligase substrate adaptor DDB1 and CUL4 Associated Factor 413337
6s658298Pre-clinical development of gene modification of hematopoietic stem cells with chimeric antigen receptors for cancer immunotherapy10334

Note: Due to the evolving nature of web traffic, the data presented here should be considered approximate and subject to revision. Learn more.